David F. McDermott
17 Podcast Episodes
The role of immune checkpoint inhibitors and VEGF TKIs in the adjuvant treatment of renal cell carcinoma - interview with David F. McDermott
The role of immune checkpoint inhibitors and VEGF TKIs in the adjuvant treatment of renal cell carcinoma - interview with David F. McDermott
Prof. David F. McDermott shared his thoughts in the kidney cancer filed. What was the biggest changes in the last six mo... Read more
10 Mar 2022
•
5mins
Toni K. Choueiri, MD / David F. McDermott, MD / Nizar M. Tannir, MD, FACP - At the Therapeutic Crossroads for RCC: Investigating the Current Applications, Controversies, and Future Use of Immunotherapy and Targeted Agents
Toni K. Choueiri, MD / David F. McDermott, MD / Nizar M. Tannir, MD, FACP - At the Therapeutic Crossroads for RCC: Investigating the Current Applications, Controversies, and Future Use of Immunotherapy and Targeted Agents
Go online to PeerView.com/QRQ860 to view the activity, download slides and practice aids, and complete the post-test to ... Read more
4 Jan 2021
•
1hr 3mins
Similar People
Petros Grivas
Suresh S. Ramalingam
John J. Russell
Thomas Powles
Maha Hussain
Javed Butler
Melissa Wasserstein
Robert Dreicer
Suzanne Lentzsch
Ashish M. Kamat
Rajiv Agarwal
Jennifer Wargo
Anna F. Farago
Kimberly Halla
Erik P. Sulman
Toni K. Choueiri, MD / David F. McDermott, MD / Nizar M. Tannir, MD, FACP - At the Therapeutic Crossroads for RCC: Investigating the Current Applications, Controversies, and Future Use of Immunotherapy and Targeted Agents
Toni K. Choueiri, MD / David F. McDermott, MD / Nizar M. Tannir, MD, FACP - At the Therapeutic Crossroads for RCC: Investigating the Current Applications, Controversies, and Future Use of Immunotherapy and Targeted Agents
Go online to PeerView.com/QRQ860 to view the activity, download slides and practice aids, and complete the post-test to ... Read more
4 Jan 2021
•
1hr 3mins
Toni K. Choueiri, MD / David F. McDermott, MD / Nizar M. Tannir, MD, FACP - At the Therapeutic Crossroads for RCC: Investigating the Current Applications, Controversies, and Future Use of Immunotherapy and Targeted Agents
Toni K. Choueiri, MD / David F. McDermott, MD / Nizar M. Tannir, MD, FACP - At the Therapeutic Crossroads for RCC: Investigating the Current Applications, Controversies, and Future Use of Immunotherapy and Targeted Agents
Go online to PeerView.com/QRQ860 to view the activity, download slides and practice aids, and complete the post-test to ... Read more
4 Jan 2021
•
1hr 3mins
Most Popular
Elon Musk
Barack Obama
Bill Gates
LeBron James
Mark Cuban
Michelle Obama
Melinda Gates
Arnold Schwarzenegger
Kevin Hart
Terry Crews
Mike Tyson
Toni K. Choueiri, MD / David F. McDermott, MD / Nizar M. Tannir, MD, FACP - At the Therapeutic Crossroads for RCC: Investigating the Current Applications, Controversies, and Future Use of Immunotherapy and Targeted Agents
Toni K. Choueiri, MD / David F. McDermott, MD / Nizar M. Tannir, MD, FACP - At the Therapeutic Crossroads for RCC: Investigating the Current Applications, Controversies, and Future Use of Immunotherapy and Targeted Agents
Go online to PeerView.com/QRQ860 to view the activity, download slides and practice aids, and complete the post-test to ... Read more
4 Jan 2021
•
1hr 3mins
Toni K. Choueiri, MD / David F. McDermott, MD / Nizar M. Tannir, MD, FACP - At the Therapeutic Crossroads for RCC: Investigating the Current Applications, Controversies, and Future Use of Immunotherapy and Targeted Agents
Toni K. Choueiri, MD / David F. McDermott, MD / Nizar M. Tannir, MD, FACP - At the Therapeutic Crossroads for RCC: Investigating the Current Applications, Controversies, and Future Use of Immunotherapy and Targeted Agents
Go online to PeerView.com/QRQ860 to view the activity, download slides and practice aids, and complete the post-test to ... Read more
4 Jan 2021
•
1hr 3mins
Toni K. Choueiri, MD / David F. McDermott, MD / Nizar M. Tannir, MD, FACP - At the Therapeutic Crossroads for RCC: Investigating the Current Applications, Controversies, and Future Use of Immunotherapy and Targeted Agents
Toni K. Choueiri, MD / David F. McDermott, MD / Nizar M. Tannir, MD, FACP - At the Therapeutic Crossroads for RCC: Investigating the Current Applications, Controversies, and Future Use of Immunotherapy and Targeted Agents
Go online to PeerView.com/QRQ860 to view the activity, download slides and practice aids, and complete the post-test to ... Read more
4 Jan 2021
•
1hr 3mins
David F. McDermott, MD - Redefining the Management of Advanced RCC: An Expert Tumor Board on Rational Selection, Sequencing, and Combination of Targeted Agents and Immunotherapy
David F. McDermott, MD - Redefining the Management of Advanced RCC: An Expert Tumor Board on Rational Selection, Sequencing, and Combination of Targeted Agents and Immunotherapy
Go online to PeerView.com/FPP860 to view the activity, download slides and practice aids, and complete the post-test to ... Read more
13 Sep 2019
•
1hr 7mins
David F. McDermott, MD - Redefining the Management of Advanced RCC: An Expert Tumor Board on Rational Selection, Sequencing, and Combination of Targeted Agents and Immunotherapy
David F. McDermott, MD - Redefining the Management of Advanced RCC: An Expert Tumor Board on Rational Selection, Sequencing, and Combination of Targeted Agents and Immunotherapy
Go online to PeerView.com/FPP860 to view the activity, download slides and practice aids, and complete the post-test to ... Read more
13 Sep 2019
•
1hr 7mins
David F. McDermott, MD - Redefining the Management of Advanced RCC: An Expert Tumor Board on Rational Selection, Sequencing, and Combination of Targeted Agents and Immunotherapy
David F. McDermott, MD - Redefining the Management of Advanced RCC: An Expert Tumor Board on Rational Selection, Sequencing, and Combination of Targeted Agents and Immunotherapy
Go online to PeerView.com/FPP860 to view the activity, download slides and practice aids, and complete the post-test to ... Read more
29 Aug 2019
•
1hr 7mins
